Venture Capital

Tech firm unspun is using AI-powered 3D weaving to bring apparel manufacturing back to the U.S., cutting waste and revolutionizing retail supply chains.

With millions of illegal school bus passings a year, new tech like extended stop arms offers a proactive solution. But can it overcome cost and driver apathy?

A new award-winning serum promises 'glass skin' and enhances injectable results, tapping into a multi-billion dollar market. Here's the science behind it.

A new white paper details how the BioShare platform helps research institutions navigate the NIH's complex and costly new cybersecurity requirements.

Pacific Office Automation's buyout of Western Business Products closes a key geographic gap, signaling a larger strategy in a consolidating industry.

For decades, toxic chemicals were the norm in HVACR. See how one family business's commitment to safety led to explosive growth and industry-wide change.

After seven years in stealth, Madrid-based Xoople emerges with unicorn status to commercialize a satellite data platform for the coming agentic AI era.

With new funding and a powerful Falcon engine, NeuBird AI aims to end IT chaos by preventing outages before they happen. Here's how it works.

With the hire of revenue guru Kevin Delane, AI data leader DDN signals an aggressive push for global dominance and readies its engine for a potential IPO.

Vyome is set to present promising Phase 2 data for VT-1953, a first-in-class treatment for a debilitating cancer complication with no approved drugs.

In a pivotal move from R&D to commercial scale, Zivo Bioscience partners with industry leader Cyanotech to meet global demand for its unique algal biomass.

This April, families nationwide are walking to fund a new strategy for Lennox-Gastaut Syndrome, aiming to slash diagnosis times and find real cures.

With a $5M private placement, Ubercrete is one step closer to a public listing and revolutionizing the construction industry with its advanced concrete tech.

MTI replaces its Road Tour with an intense, invite-only forum, uniting top regulators and experts to find the next wave of healthcare solutions.

The junior explorer has applied to go public on the CSE, aiming to capitalize on soaring metal prices. But what are the risks and rewards for investors?

As 'forever chemicals' plague South Florida, a new, costly plasma exchange therapy offers a solution. But is it a medical breakthrough or a luxury trend?

President Trump's 100% tariff on imported drugs aims to secure the US supply chain, but the policy's success may hinge on unproven and unverified players.

Biopharma firm GENFIT sees soaring Iqirvo sales and a cash runway past 2028, overshadowing a net loss driven by strategic, non-cash write-downs.

Manufacturers are spending millions on ERP systems with poor results. Discover why a 'process-first' approach is becoming critical for survival and growth.

A new strategic alliance aims to transform media workflows. Learn how advanced AI will change content discovery, personalization, and revenue generation.